These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6180483)

  • 1. [Interferon and antirabies vaccination].
    Atanasiu P
    Salud Publica Mex; 1982; 24(2):123-9. PubMed ID: 6180483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of interferon induced by rabies vaccines (author's transl)].
    Nozaki J; Atanasiu P
    Ann Microbiol (Paris); 1975; 126(3):381-8. PubMed ID: 1211717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral action of interferon in animal systems: effect of interferon on rabies infections of animals.
    Baer GM
    Tex Rep Biol Med; 1977; 35():461-71. PubMed ID: 99831
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune effector mechanisms required for protection to rabies virus.
    Xiang ZQ; Knowles BB; McCarrick JW; Ertl HC
    Virology; 1995 Dec; 214(2):398-404. PubMed ID: 8553540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interleukin-10 associated with low IL-6 concentration correlated with greater survival rates in mice infected by rabies virus vaccinated against it and immunomodulated with P. acnes.
    Megid J; Kaneno R; Nozaki CN; Brito CJ; Almeida MF
    Comp Immunol Microbiol Infect Dis; 2004 Nov; 27(6):393-411. PubMed ID: 15325513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Presence of an active substance of the interferon type with respect to street rabies, in extracts of tissues infected with vaccine].
    Bahmanyar M; Fayaz A; Vieuchange J
    C R Seances Soc Biol Fil; 1967 Jul; 161(2):255-8. PubMed ID: 4229118
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro stimulation of rabbit lymphocytes after immunization with live and inactivated rabies vaccines.
    Wiktor TJ; Kamo I; Koprowski H
    J Immunol; 1974 Jun; 112(6):2013-9. PubMed ID: 4825784
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preventive antirabies vaccination. Evaluation of humoral immunity].
    Lery N; Lery L
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):121-33. PubMed ID: 7181561
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune responses to nucleic acid vaccines to rabies virus.
    Xiang ZQ; Spitalnik SL; Cheng J; Erikson J; Wojczyk B; Ertl HC
    Virology; 1995 Jun; 209(2):569-79. PubMed ID: 7778289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the degree of antirabies immunity in mice with different capabilities for interferon formation].
    Karakuiumchian MK; Bektemirova MS; Polkovnikova VIa
    Vopr Virusol; 1973; 18(3):275-7. PubMed ID: 4769528
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
    Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
    Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rabies vaccine in Czechoslovakia. I. Hempt's vaccine and its modification].
    Slonim D; Stastný F; Brázdová AR
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):257-65. PubMed ID: 6215991
    [No Abstract]   [Full Text] [Related]  

  • 13. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
    Pastoret PP; Brochier B; Boulanger D
    Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein.
    Saxena S; Sonwane AA; Dahiya SS; Patel CL; Saini M; Rai A; Gupta PK
    Vet Microbiol; 2009 Apr; 136(1-2):36-44. PubMed ID: 19081687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon inducing activity of rabies cell culture vaccine in humans].
    Atanasiu P; Yokota Y; Gamet A
    Ann Microbiol (Paris); 1979; 130(2):273-6. PubMed ID: 39484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ; Yang Y; Wilson JM; Ertl HC
    Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.